We are live on
!
Find out more
PI
Pettee Investors Portfolio holdings
AUM
$194M
1-Year Est. Return
21.67%
This Fund
S&P 500
This Quarter
Est. Return
+0.04%
1 Year Est. Return
+21.67%
3 Year Est. Return
+66.94%
5 Year Est. Return
+88.75%
10 Year Est. Return
+290.65%
AUM
$103M
AUM Growth
-$318K
(-0.31%)
Cap. Flow
+$152K
Cap. Flow
% of AUM
0.15%
Top 10 Holdings %
Top 10 Hldgs %
55.4%
Holding
61
New
2
Increased
7
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$211K |
| 2 |
Caterpillar
CAT
|
+$203K |
| 3 |
Intel
INTC
|
+$75.2K |
| 4 |
DuPont de Nemours
DD
|
+$30.7K |
| 5 |
CELG
Celgene Corp
CELG
|
+$28.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$249K |
| 2 |
Travelers Companies
TRV
|
+$216K |
| 3 |
ExxonMobil
XOM
|
+$8.6K |
| 4 |
Walt Disney
DIS
|
+$5.49K |
| 5 |
SLB Ltd
SLB
|
+$4.51K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.53% |
| 2 | Consumer Staples | 13.34% |
| 3 | Energy | 11.3% |
| 4 | Financials | 10.01% |
| 5 | Industrials | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$618B
| $15.6M | 15.13% |
159,596
| – | – |
|
|
2
ExxonMobil
XOM
$644B
| $7.76M | 7.55% |
93,268
-100
| -0.1% | -$8.6K |
|
3
JPMorgan Chase
JPM
$935B
| $7.04M | 6.85% |
103,940
+400
| +0.4% | +$26.1K |
|
4
Pfizer
PFE
$143B
| $5.89M | 5.73% |
185,172
-2
| -0% | -$65 |
|
5
Procter & Gamble
PG
$336B
| $4.14M | 4.02% |
52,866
| – | – |
|
6
Bristol-Myers Squibb
BMY
$133B
| $4.12M | 4.01% |
61,941
| – | – |
|
7
GE Aerospace
GE
$374B
| $3.36M | 3.27% |
26,419
+167
| +0.6% | +$21.7K |
|
|
8
Walt Disney
DIS
$167B
| $3.14M | 3.06% |
27,530
-50
| -0.2% | -$5.49K |
|
9
PepsiCo
PEP
$190B
| $3M | 2.92% |
32,190
| – | – |
|
|
10
DuPont de Nemours
DD
$18.5B
| $2.93M | 2.85% |
22,604
+237
| +1% | +$30.7K |
|
|
11
Intel
INTC
$455B
| $2.48M | 2.41% |
81,474
+2,325
| +3% | +$75.2K |
|
12
IBM
IBM
$211B
| $2.42M | 2.35% |
15,564
| – | – |
|
13
Merck
MRK
$322B
| $2.21M | 2.15% |
40,640
| – | – |
|
|
14
Clorox
CLX
$11.6B
| $2.17M | 2.11% |
20,895
-2,305
| -10% | -$249K |
|
15
AbbVie
ABBV
$443B
| $2.08M | 2.03% |
31,018
| – | – |
|
16
Chevron
CVX
$392B
| $2.06M | 2.01% |
21,369
| – | – |
|
|
17
SLB Ltd
SLB
$73.6B
| $1.8M | 1.75% |
20,853
-50
| -0.2% | -$4.51K |
|
18
Abbott
ABT
$183B
| $1.7M | 1.66% |
34,693
| – | – |
|
19
McCormick & Company Non-Voting
MKC
$13.7B
| $1.54M | 1.5% |
37,996
| – | – |
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| $1.44M | 1.4% |
12,446
+250
| +2% | +$28.6K |
|
|
ESRX
21
DELISTED
Express Scripts Holding Company
ESRX
| $1.42M | 1.38% |
16,009
+200
| +1% | +$17.5K |
|
22
Walmart Inc
WMT
$885B
| $1.31M | 1.27% |
55,293
| – | – |
|
23
Emerson Electric
EMR
$83.9B
| $1.29M | 1.26% |
23,261
| – | – |
|
24
American Express
AXP
$227B
| $1.17M | 1.13% |
15,000
| – | – |
|
25
McDonald's
MCD
$192B
| $1.15M | 1.12% |
12,125
| – | – |
|
Similar funds
1CP
OCA
IA
KIM
TVM
EWA
SCPM
WM
Pettee Investors's Q2 2015 Portfolio in Review
As of Q2 2015, Pettee Investors held 61 positions worth $103M, down 0.31% from $103M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 4.9%. Pettee Investors opened 2 new positions and exited 1, leaving the 61-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 36% a quarter earlier, followed by Consumer Staples and Energy.
- Pettee Investors's largest Q2 2015 buy was Philip Morris: 2,566 shares worth $206K.
- Pettee Investors added most to Intel in Q2 2015, an estimated $75.2K increase.
- Pettee Investors's biggest Q2 2015 reduction was Clorox, cutting an estimated $249K.
- Pettee Investors fully exited Travelers Companies in Q2 2015, selling an estimated $216K.
- Pettee Investors's ten largest holdings make up 55% of its $103M portfolio in Q2 2015.
- Pettee Investors opened 2 new positions and closed 1 in Q2 2015.
- Pettee Investors's portfolio value fell 0.31% quarter-over-quarter to $103M.
Based on Pettee Investors's 13F filing for Q2 2015, filed 5 Aug 2015.